Abstract:AIM: To select the peptide mimicking the neutralization epitope of hepatitis E virus which bound to non-type-specific and conformational monoclonal antibodies (mAbs) 8C11 and 8H3 fromed 7-peptide phage display library, and expressed the peptide recombinant with HBcAg in E. coli, and to observe whether the recombinant HBcAg could still form virus like particle (VLP) and to test the activation of the recombinant polyprotein and chemo-synthesized peptide that was selected by mAb 8H3.METHODS: 8C11 and 8H3 were used to screen for binding peptides through a 7-peptide phage display library. After 4 rounds of panning, monoclonal phages were selected and sequenced. The obtained dominant peptide coding sequences was then synthesized and inserted into amino acid 78 to 83 of hepatitis B core antigen (HBcAg), and then expressed in E. coli. Activity of the recombinant proteins was detected by Western blotting, VLPs of the recombinant polyproteins were tested by transmission electron microscopy and binding activity of the chemo-synthesized peptide was confirmed by BIAcore biosensor.RESULTS: Twenty-one positive monoclonal phages (10 for 8C11, and 11 for 8H3) were selected and the inserted fragments were sequenced. The DNA sequence coding for the obtained dominant peptides 8C11 (N'-His-Pro-Thr-Leu-Leu-Arg-Ile-C', named 8C11A) and 8H3 (N'-Ser-Ile-Leu-Pro-Tyr-Pro-Tyr-C', named 8H3A) were then synthesized and cloned to the HBcAg vector, then expressed in E. coli. The recombinant proteins aggregated into homodimer or polymer on SDS-PAGE, and could bind to mAb 8C11 and 8H3 in Western blotting. At the same time, the recombinant polyprotein could form virus like particles (VLPs), which could be visualized on electron micrograph. The dominant peptide 8H3A selected by mAb 8H3 was further chemo-synthesized, and its binding to mAb 8H3 could be detected by BIAcore biosensor.CONCLUSION: These results implicate that conformational neutralizing epitope can be partially modeled by a short peptide, which provides a feasible route for subunit vaccine development.

[Expression and Bioactivity Analysis of the Fusion Protein GFP-V(L) of the Neutralizing Monoclonal Antibody MA18/7 Against HBV].

High Expression of Hepatoma Associated Antigen HAb18G in Prokaryotic Cells and Study on Its Function in Vitro

Construction,expression and Activity Analysis of Arg9/human Anti-Hbsag Single Chain Antibody/egfp Fusion Gene

[Expression, Purification, and Bio-Activity Analysis of Fusion Protein HBx-EGFP-TLM].

[Construction and Expression of Single-Chain Antibody of Neutralizing Monoclonal Antibody 13D8 Against Hepatitis E Virus].

Construction and expression of human anti-HBsAg ScFv/tP fusion protein in E.coli and identification of its binding activity

An E. Coli-Produced Single-Chain Variable Fragment (scfv) Targeting Hepatitis B Virus Surface Protein Potently Inhibited Virion Secretion.

Selection of A Peptide Mimicking Neutralization Epitope of Hepatitis E Virus with Phage Peptide Display Technology

Construction, Expression and Internalization Study of Human Anti-HBsAg Single Chain Antibody/EGFP Fusion Proteins Containing Arg9

The Expression of HCG Epitope Fused to Hepatits B Virus Core Antigen.

[Cloning and Expression of Fab Gene of Mab HAb18 Against Human Hepatocellular Carcinoma].

[Expression of hepatitis C virus subunit fusion protein and analysis of its immunogenicity]

[Construction and Expression of Humanized Anti-Hbsag Scfv Targeting Interferon-Alpha in Escherichia Coli].

Humanization of Therapeutic Antibody of One Hepatitis B Virus and Identification of Its Biological Activity

Construction, expression and characterization of a fusion protein HBscFv-IFNγ in Komagatella (Pichia) pastoris X33.

Antigenicity Assay of the Expression Product of Fusion Gene of Truncated HBV Core Gene and “a” Determinant Gene

[Expression, Purification and Activity Analysis of Human Single-Chain Antibody Against Hepatocellular Cancer].

[Expression and Activity Identification of APOBEC3A-HBc Fusion Protein].

[Expression of Anti-Hbc Single-Chain Variable Fragment Mediated by Recombinant Replication Defective Adenovirus in Vitro].

Expression and Characterization of Hepatitis C Virus E2 Glycoprotein Fused to Hepatitis B Virus Pres1(21-47) Fragment in CHO Cells

Cloning and expression of fragments of fibronectin to screen hepatitis B virus surface antigen-binding domains